Ted Henderson

Mr. Ted Henderson, a member of the Board of Directors at SRS Medical, has served as a Managing Director at Schooner Capital since 2004. He currently serves as a director at a number of other healthcare portfolio companies, including 4G Clinical, Millstone Medical Outsourcing, Cartesian Therapeutics, and Velakine Therapeutics. He previously led Schooner’s investment in Mimetogen (sold to Allergan), and served as a director at Topokine Therapeutics (sold to Allergan) and Best Doctors (sold to a private equity firm).

Mr. Henderson is a cum laude graduate of Dartmouth College with an MBA from Harvard Business School.